Andreia Filipa Silva

Andreia Filipa Silva

Auto-generated profile, based on publicly available information

Andreia Filipa Silva

CNC‐UC, Center for Neuroscience and Cell Biology University of Coimbra Coimbra Portugal

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2013 in Andrology
Verified
Journal Article
Open access
PDF file
RTRenata Tavares
Renata Tavares
ASA. F. Silva
A. F. Silva
BLB. Lourenço
B. Lourenço
TSTeresa Santos
Teresa Santos
ASAna Paula SOUSA
Ana Paula SOUSA
Joao Ramalho-SantosJoao Ramalho-Santos
Joao Ramalho-Santos
Sperm chromatin/DNA damage can be measured by a variety of assays. However, it has been reported that these tests may lose prognostic value in Assisted Reproductive Technology (ART) cycles when assessed in post‐prepared samples, possibly due to the normalizing effect promoted by sperm preparation procedures. We have recently implemented a modified version of the Diff‐Quik staining assay that allows for the evaluation of human sperm chromatin status in native samples, together with standard sperm morphology assessment. However, the value of this parameter in terms of predicting in vitro fertilization (IVF) and Intracytoplasmic sperm injection (ICSI) outcomes after sperm selection is unknown. In this study, data from 138 couples undergoing in vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) treatments showed that sperm chromatin integrity was significantly improved after density gradient centrifugation and swim up (p < 0.001), but no correlations were found with fertilization or embryo development rates (p > 0.05). However, sperm samples presenting lower percentages of damaged chromatin were associated with better quality (Grade I) embryos in both ART procedures (p < 0.05) and clinical pregnancy among IVF couples (p < 0.05). Furthermore, regression analysis confirmed the clinical value of Diff‐Quik staining in predicting IVF (but not ICSI) clinical pregnancy (OR: 0.927, 95% CI: 0.871–0.985, p = 0.015), and a threshold value of 34.25% for this parameter was established. The proportion of IVF couples achieving a clinical pregnancy was reduced 1.9‐fold when the percentage of abnormal dark staining was ≥34.25% (p = 0.05). In conclusion, the Diff‐Quik staining assay provides useful information regarding ART success, particularly in IVF cycles, where some degree of ‘natural’ sperm selection may occur; but not in ICSI, where sperm selection is operator dependent. This quick and low‐cost assay is suggested as an alternative method to detect sperm chromatin status in minimal clinical settings, when no other well‐established and robust assays (e.g. Sperm chromatin structure assay, terminal deoxynucleotidyl transferase‐mediated dUDP nick‐end labelling) are available.

20 October 2016 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SASandra Amaral
Sandra Amaral
RTRenata Tavares
Renata Tavares
MBM. Baptista
M. Baptista
MSM. I. Sousa
M. I. Sousa
ASA. Silva
A. Silva
Joao Ramalho-SantosJoao Ramalho-Santos
Joao Ramalho-Santos
During the last decade, several studies have shown that mitochondrial parameters, such as integrity, respiratory activity, membrane potential and ROS production are intimately linked with sperm quality. Given the limitations of conventional semen analyses in terms of predicting male fertility, an increasing number of studies are focusing on the characterization of sperm mitochondria in order to more accurately assess sperm functionality. Moreover, mitochondria from several organs, such as the liver, have been described as a powerful screening tool for drug safety, being an easy in vitro model to assess the toxicity of distinct families of compounds. Given that mitochondrial functionality is intimately related to sperm homeostasis, it has become important to understand how compounds, ranging from dietary supplements, environmental pollutants, dependency-inducing drugs to pharmacological agents (such as erectile dysfunction-targeted drugs and male contraceptives) affect sperm mitochondrial function. In this review, we discuss studies describing the effects of various chemical agents on spermatozoa, with particular emphasis on mitochondrial function. From the extensive literature analyzed, we conclude that in some cases the role of sperm mitochondria as putative predictors of sperm functionality is very obvious, while in others further studies are needed to clarify this issue.

27 September 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
RPRita I. Pacheco
Rita I. Pacheco
MCMaria I. Cristo
Maria I. Cristo
Sandra AnjoSandra Anjo
Sandra Anjo
ASAndreia F. Silva
Andreia F. Silva
MSMaria Inês Sousa
Maria Inês Sousa
SASandra Gomes Amaral
Sandra Gomes Amaral
The global trend of rising (male) infertility is concerning, and the unidentifiable causes in half of the cases, the so-called unknown origin male infertility (UOMI), demands a better understanding and assessment of both external/internal factors and mechanisms potentially involved. In this work, it was our aim to obtain new insight on UOMI, specifically on idiopathic (ID) and Unexplained male infertility (UMI), relying on a detailed evaluation of the male gamete, including functional, metabolic and proteomic aspects. For this purpose, 1114 semen samples, from males in couples seeking infertility treatment, were collected at the Reproductive Medicine Unit from the Centro Hospitalar e Universitário de Coimbra (CHUC), from July 2018–July 2022. Based on the couples’ clinical data, seminal/hormonal analysis, and strict eligibility criteria, samples were categorized in 3 groups, control (CTRL), ID and UMI. Lifestyle factors and anxiety/depression symptoms were assessed via survey. Sperm samples were evaluated functionally, mitochondrially and using proteomics. The results of Assisted Reproduction Techniques were assessed whenever available. According to our results, ID patients presented the worst sperm functional profile, while UMI patients were similar to controls. The proteomic analysis revealed 145 differentially expressed proteins, 8 of which were specifically altered in ID and UMI samples. Acrosin (ACRO) and sperm acrosome membrane-associated protein 4 (SACA4) were downregulated in ID patients while laminin subunit beta-2 (LAMB2), mannose 6-phosphate isomerase (MPI), ATP-dependent 6-phosphofructokinase liver type (PFKAL), STAR domain-containing protein 10 (STA10), serotransferrin (TRFE) and exportin-2 (XPO2) were downregulated in UMI patients. Using random forest analysis, SACA4 and LAMB2 were identified as the sperm proteins with a higher chance of distinguishing ID and UMI patients, and their function and expression variation were in accordance with the functional results. No alterations were observed in terms of lifestyle and psychological factors among the 3 groups. These findings obtained in an experimental setting based on 3 well-defined groups of subjects, might help to validate new biomarkers for unknown origin male infertility (ID and UMI) that, in the future, can be used to improve diagnostics and treatments.

17 June 2016 in Andrology
Verified
Journal Article
Closed access
PDF file
SES. Escada‐Rebelo
S. Escada‐Rebelo
ASA. F. Silva
A. F. Silva
SASandra Amaral
Sandra Amaral
RTRenata Tavares
Renata Tavares
CPC. Paiva
C. Paiva
PMP. C. Mota
P. C. Mota

6 April 2021 in The European Journal of Contraception & Reproductive Health Care
Verified
Journal Article
Open access
MAMaria Inês Alfaiate
Maria Inês Alfaiate
RSRita António Santos
Rita António Santos
ASAndreia Filipa Silva
Andreia Filipa Silva
ASAna Paula SOUSA
Ana Paula SOUSA
TSTeresa Santos
Teresa Santos
RTRenata Tavares
Renata Tavares
Spermicides have been identified as a potentially attractive alternative to hormonal contraceptives and/or intrauterine devices. Thus, this study aimed evaluating the efficacy and local tolerance o...

19 August 2026 in Obesity Reviews
Verified
Journal Article
Open access
PDF file
MKMaria Kafyra
Maria Kafyra
PAPelin Alpay
Pelin Alpay
AAAnabela Marisa Azul
Anabela Marisa Azul
Fernando Fernández-ArandaFernando Fernández-Aranda
Fernando Fernández-Aranda
SFSarah Forberger
Sarah Forberger
OBObeclust
Obeclust
Obesity remains one of the most pressing public health challenges in Europe, with substantial health, social, and economic consequences. Despite extensive research and numerous national strategies, obesity prevention efforts remain fragmented across countries, limiting comparability, scalability, and policy impact. The present description introduces the collaborative effort of “ OBEClust ,” a pan‐European initiative designed to harmonize obesity prevention research and policy, fostering collaboration across disciplines, sectors, and countries. OBEClust aims to create a coordinated framework that integrates research methodologies, shared data infrastructures, and knowledge translation approaches to strengthen the evidence base and support the development and implementation of effective and equitable obesity prevention strategies. The initiative brings together researchers, policymakers, and public health stakeholders to standardize core indicators, align evaluation frameworks, and promote evidence‐informed policy development. By facilitating cross‐country collaboration and reducing duplication of efforts, OBEClust seeks to strengthen capacity for prevention research and accelerate the implementation of effective interventions. Through harmonization and structured knowledge exchange, OBEClust addresses existing gaps between scientific evidence and policy action. This initiative provides a collaborative framework for European obesity research coordination that provides a transferable model for cross‐project cooperation through methodological harmonization, structured knowledge exchange, stakeholder engagement, and evidence translation.